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Abstract: Monoamine oxidase (MAO) enzymes catalyze the 
degradation of a very broad range of biogenic and dietary amines 
including many neurotransmitters in the brain, whose imbalance is 
extensively linked with the biochemical pathology of various 
neurological disorders. Although sharing around 70% sequence 
identity, both MAO A and B isoforms differ in substrate affinities and 
inhibitor sensitivities. Inhibitors that act on MAO A are used to treat 
depression, due to their ability to raise serotonin concentrations, 
while MAO B inhibitors decrease dopamine degradation and improve 
motor control in patients with Parkinson disease. Despite this 
functional importance, the contributions affecting MAO selectivity are 
poorly understood. Here we used a combination of MD simulations, 
MM–PBSA binding free energy evaluations, and QM cluster 
calculations to address the unexpected, yet challenging MAO B 
selectivity for N-methylhistamine (NMH) over histamine (HIS), 
differing only in a single methyl group distant from the reactive 
ethylamino centre. We show that a dominant selectivity contribution 
is offered by a lower activation free energy for NMH by 2.6 kcal mol–1, 
in excellent agreement with the experimental ∆∆G‡EXP = 1.4 kcal 
mol–1, together with a more favourable reaction exergonicity and 
active site binding. This study also confirms the hydrophobic nature 
of the MAO B active site and underlines the important role of Ile199, 
Leu171 and Leu328 in properly orienting substrates for the reaction. 
Introduction 
Histamine (HIS) is an important mediator of many biological 
processes including inflammation, gastric acid secretion, 
neuromodulation, and regulation of immune function. It is formed 
by decarboxylation of the amino acid L-histidine in a reaction 
catalyzed by the histidine decarboxylase, and by microbiological 
action in the course of food processing, thus making it present in 
substantial amounts in many fermented foodstuffs and 
beverages, such as aged cheese, red wine, and sauerkraut. Due 
to its potent pharmacological activity even at very low 
concentrations, the synthesis, transport, storage, release and 
degradation of histamine have to be carefully regulated to avoid 
adverse reactions, since it can even be toxic when it is present 
either in excess or in the wrong metabolic context.[1] Histamine 
exhibits its diverse biological actions by binding to and thereby 
activating four different G-protein coupled receptors located at 
the surface of histamine responsive cells. The primary goal of 
histamine inactivation is its conversion to metabolites that will 
not activate histamine receptors, and this is achieved either by 
the methylation of the imidazole ring, catalyzed by histamine N-
methyltransferase (HMT), or by the oxidative deamination of the 
primary amino group, catalyzed by diamine oxidase (DAO) 
(Scheme 1).[2]  
 
Scheme 1. Metabolic degradation of histamine (HIS) to the corresponding 
aldehyde directly catalyzed by diamine oxidase (DAO), or by monoamine 
oxidase (MAO) but only after HIS is converted to N-methylhistamine (NMH) 
with histamine methyltransferase (HMT). 
HMT catalyzes the transfer of a methyl group from S-
adenosyl-L-methionine to the secondary imidazole amino group 
forming N-methylhistamine (NMH), and is a highly specific 
enzyme that does not show significant methylation of other 
substrates. NMH is not active at the histamine receptor sites, 
and is further metabolized by monoamine oxidase (MAO), a 
primary degradation enzyme for a very broad range of 
structurally and chemically different biogenic and dietary amines 
in cells,[3] including amine neurotransmitters in the brain, which 
is why it has been the central pharmacological target for treating 
depression and Parkinson’s disease for over 60 years.[4]  
MAO is a mitochondrial outer membrane-bound flavoenzyme 
that catalyzes the oxidative deamination of amines into their 
corresponding imines, which are then non-enzymatically 
hydrolyzed to the final carbonyl compounds and ammonia. The 
enzyme itself is regenerated to its active form by molecular 
oxygen, O2, which is in turn reduced to hydrogen peroxide, H2O2, 
according to the overall equation: 
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MAOs operate using the flavin adenine dinucleotide (FAD) 
cofactor, which is, in contrast to the majority of other 
flavoenzymes, covalently bound to a cysteine through an 8α-
thioether linkage (Figure 1). During the catalytic reaction, FAD is 
reduced to FADH2 by accepting two protons and two electrons 
from the substrate. Although having around 70% sequence 
identities and a conserved pentapeptidic sequence (Ser-Gly-Gly-
Cys-Tyr) that binds the identical FAD cofactor,[5] both the A and 
the B isoforms of the enzyme differ on the basis of their 
substrate affinities and inhibitor sensitivities,[6] but it is assumed 
they act by the same mechanism. Each isoform is present in 
specific subsets of neurons, where they metabolize 
neurotransmitters, and both are found in liver, where biogenic 
amines are rapidly metabolized to less bioactive forms for 
excretion. Inhibition of MAOs has a notable neuroprotective 
effect, since the MAO catalyzed reactions yield neurotoxic 
products such as hydrogen peroxide and aldehydes.[7,8] However, 
despite tremendous research efforts devoted to MAOs over 
several decades, neither the catalytic nor the inhibition 
mechanisms of MAO have yet been unambiguously established. 
 
Figure 1. Position of the active site within the MAO B crystal structure 
(2XFN.pdb) indicating the flavin cofactor (FAD) and three tyrosine residues 
that all form the "aromatic cage" structural feature. Atom numbering of the 
FAD fragment is shown in the bottom-right box. 
Recently, we performed the first quantum mechanical study 
that demonstrated the prevailing feasibility of the two-step direct 
hydride transfer mechanism over several alternative pathways 
for the dopamine degradation using QM-only cluster model of 
the MAO B enzyme.[9] This study was later extended by 
considering the full enzyme dimensionality through the empirical 
valence bond QM/MM approach, which gave the activation free 
energy of 16.1 kcal mol–1,[10] being in excellent agreement with 
the experimentally determined value of 16.5 kcal mol–1,[11] thus 
supporting the proposed hydride transfer mechanism. Our 
mechanistic picture is already gaining some affirmation in the 
literature,[12] and is fully corroborated by a very recent 13C kinetic 
isotope effect measurements on a related polyamine oxidase 
flavoenzyme.[13] The focus of the present work will be on 
employing this mechanism in understanding differences in HIS 
and NMH degradation. 
After successful heterologous over-expression and 
purification of recombinant human MAO in yeast,[14] the three-
dimensional structures of human MAO A and MAO B have been 
solved at a resolution of 2.2 Å and 1.65 Å, respectively.[15,16] 
These showed that the active-site cavities are reached from the 
flavin-binding site at the core to the surface of the protein and 
are mainly hydrophobic, ending in an "aromatic cage" near the 
flavin where three tyrosines align the substrate towards the N5–
C4a region of the flavin (Figure 1). Mutational studies of these 
residues in MAO B[17] have shown that even though none of 
these residues is essential to catalysis, the affinity for and 
turnover of substrates is significantly altered in the mutants. For 
example, the Km value for benzylamine increases by more than 
10-fold in the Tyr435Phe mutant.[17] These residues also exert a 
dipole effect on the substrate that can make the amine more 
susceptible to oxidation.[17] Therefore, key features for substrate-
positioning in the active site are proximity and orientation relative 
to the N5–C4a region of the flavin ring (Figure 1). 
The notion and experimentally observed fact that HIS is not 
a physiological MAO substrate, whereas NMH is,[18] poses a 
very important and intriguing question: for a promiscuous 
enzyme such as MAO, what is the origin of its unexpected 
selectivity towards two very similar compounds, yet completely 
identical in their reactive ethylamino chain parts? The answer to 
this question might turn significant in designing novel and more 
efficient MAO inhibitors that are all in the clinical use as 
antidepressant and antiparkinsonian drugs,[6,19] while obtained 
results should suggest guidelines for the modification of the 
reactivity of these enzymes, providing achievements for the 
biotechnology and rational protein engineering. In the present 
study we used a combination of molecular dynamics (MD) 
simulations, MM-PBSA binding free energy calculations and 
quantum mechanical cluster approach to computationally 
address, for the first time in the literature, the substrate 
specificity of MAO B with two substrates, histamine (HIS) and N-
methylhistamine (NMH), differing only in a single methyl group 
far away from the reactive centre.  
Results and Discussion 
Molecular Dynamics Simulations. Our analysis was initiated 
by examining the conformational flexibility of HIS and NMH 
molecules within the MAO B active site. For that purpose, 
classical MD simulations were performed and their stability was 
evaluated by analyzing the Root Mean Squared Deviation 
(RMSD) as a function of time, which measures how much the 
protein structure changes over the course of the simulation 
(Figure S1). The RMSDs for both substrates were not so much 
different from each other, and during the first 100 ns, RMSDs of 
all complexes were steadily increased as the enzyme deviated 
from its initial structure. After the initial 150 ns, the RMSD values 
cluster and remain in a narrow range around 2.5 Å, confirming 
the validity of the employed simulation times.  
We monitored the orientation of substrates relative to the 
enzyme FAD co-factor with particular focus on the distance 
between the α–carbon on the substrate and the N5 atom on the 
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FAD co-factor (Figure 2) as these two sites represent the 
abstracting and accepting centres for the hydride transfer,[9,10,20] 
respectively, and their close vicinity assures substrate reactive 
conformation. Visual inspection of the evolution of these 
distances indicates that, for the NMH substrate, there is 
practically always a reactive conformation in either of the two 
MAO B subunits associated with αC(substrate)–N5(FAD) 
distances between 3–4 Å. This agrees with our earlier DFT 
calculated value of 3.198 Å in the Michaelis complex of 
dopamine within a cluster model of the MAO B enzyme,[9] and 
the results presented later. In contrast, simulations with the HIS 
substrate reveal that in one MAO B subunit a reactive 
conformation is even never achieved as, during the first 200 ns, 
all αC(substrate)–N5(FAD) distances are found well above 4 Å, 
and then start reaching values as high as 8–14 Å in the last 100 
ns of simulations (Figure 2), which indicates substrate departure 
from the active site. These observations are further supported by 
the calculated average αC(substrate)–N5(FAD) distances during 
the whole 300 ns MD simulations, which are 4.994 and 6.224 Å 
for NMH in both enzyme subunits, while are increased to 5.820 
and 7.243 Å for HIS. Taken all together, these results indicate 
that it is somewhat easier for NMH to achieve reactive 
conformations within the active site, which represents a small 
contribution towards the selectivity of MAO B for this substrate. 
 
 
Figure 2. Evolution of the αC(substrate)–N5(FAD) distances during MD 
simulations for monocationic N-methylhistamine (top) and histamine (bottom) 
within the MAO B active site. The values corresponding to each of the enzyme 
subunits are indicated with red and black colours.  
From these MD simulations, we identified three major 
reasons to why NMH is better anchored within the enzyme, thus 
better prepared for the catalytic step (representative structures 
are shown in Figure 3). Firstly, it appears that during simulations 
NMH prefers the gauche conformation in which there is an 
intramolecular hydrogen bond between its ethylamino group and 
the imidazole imino nitrogen (Scheme 2), while HIS is mostly 
found in the trans conformation, the latter being its most 
dominant physiological form.[21] This is evident upon inspecting 
the distances between the relevant ring imino- and chain amino 
nitrogen atoms (Figure S2), which give averages of 3.403 and 
4.043 Å for NMH in both MAO B subunits, while are significantly 
higher at 4.490 and 4.745 Å for HIS, thus clearly indicating a 
larger preference for the intramolecular hydrogen bonding in 
NMH. Although, during MD simulations, the conformational 
preferences of substrate molecules are modulated by the protein 
binding pocket and the results may not necessarily reflect the 
preferences of the unbound systems, a possible explanation for 
this trend is offered by analyzing the corresponding pKa values. 
 
Figure 3. Representative structure of the most populated cluster of MAO B in 
complex with N-methylhistamine (left) and histamine (right) obtained after the 
clustering analysis of the corresponding MD trajectories. N-methylhistamine is 
properly positioned for the chemical reaction orienting its ethylamino group 
towards the N5 atom of the FAD co-factor. 
Interestingly, while basicities of ring imino nitrogens in NHM 
and HIS are identical (both pKa values reported at 5.8),[22] the 
basicity of the ethylamino group in NMH is slightly lower (pKa = 
9.57 vs. pKa = 9.75 in HIS),[22] thus suggesting slightly higher 
acidity of the corresponding –NH3+ moiety in NMH. This implies 
that the cationic ethylamino group in NMH is somewhat more 
likely to form the intramolecular hydrogen bonding than in HIS, 
as it, for example, follows from the proposed pKa slide rule.[23] 
This gauche conformation results in a more rigid and compact 
structure of NMH, which is less likely to move around the active 
site, and once it establishes a reactive conformation it remains in 
it for a longer time. In contrast, the preferred trans conformation 
of HIS makes it more flexible, thus allowing it to assume many 
orientations other the necessary reactive ones. Secondly, the 
imidazole ring in HIS has an acidic N–H group, permitting 
unreactive conformations to be achieved by its ability to form 
hydrogen bonds with active site residues, particularly interesting 
being those with the N5 atom and the near carbonyl group on 
the FAD co-factor (Figure 1). Since the former site is responsible 
for the C(α)–hydride abstraction, this hinders the HIS reactivity. 
 
Scheme 2. Possible trans and gauche conformations of the monocationic 
histamine (HIS, R = H) and N-methylhistamine (NMH, R = Me). 
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The mentioned hydrogen bonds are further promoted by the 
stabilizing π–π stacking interactions of the HIS imidazole ring 
with the phenyl rings of the "aromatic cage" Tyr398 and Tyr435 
(Figure 3), which all position the converting ethylamino group far 
from the enzyme co-factor and disable the catalysis. Thirdly, the 
substitution of the acidic imidazole N–H fragment in HIS with the 
N–Me group in NMH strongly favours hydrophobic interactions 
within the demonstrated hydrophobic nature of the MAO B active 
site[24] especially with the side chains of Leu171, Ile199 and 
Leu328 (Figure S3) that keep NMH anchored in the active site 
and properly oriented for the reaction. As expected, for around 
half of the simulation time, HIS makes no interactions with any of 
the three mentioned residues, while during the rest of 
simulations the number of interactions is mostly between 0 and 
1. In contrast, NMH always forms hydrophobic contacts with at 
least one of those residues, and frequently with all three (Figure 
S3). It seems that particularly significant are interactions with 
Ile199, which was experimentally proposed as the "gating 
residue" in MAO B,[25,26] in some studies together with Tyr326.[27] 
Interestingly, Ile199 is conserved in all known MAO B 
sequences except bovine MAO B, which has Phe in this position 
that is, in turn, a conserved residue in the analogous position in 
MAO A. It is suggested that in a "closed conformation", Ile199 
separates hydrophobic entrance- and substrate cavities in MAO 
B thus producing a bipartite configuration of the active site, while 
its "open conformation" allows the fusion of both cavities to a 
large total volume of ~700 Å3, much larger than a monopartite 
substrate cavity of ~550 Å3 in MAO A, and a successful 
substrate or inhibitor binding.[25,26] Conversion of Ile and Tyr 
gating side chains to Ala residues in MAO B resulted in no major 
structural alterations in the active site, but the double-mutated 
enzyme exhibits inhibitor-binding properties more similar to 
those of MAO A than to MAO B,[27] which together with the 
observation that Ile199Ala mutant show an increase in binding 
affinity for reversible MAO B inhibitors that bridge both 
cavities,[27] underlines a critical role of Ile199 in determining 
substrate and inhibitor binding specificity for MAO B. The results 
presented here provide further confirmation in this direction as 
this insight should prove valuable in the design of high affinity 
and specific reversible MAO B inhibitors. 
In order to quantify these observations, we employed MM–
PBSA analysis to estimate the absolute binding free energies for 
both NMH and HIS within the MAO B active site and to obtain 
detailed information about energetic contributions that govern 
these interactions (Table 1). Looking first at the overall binding 
free energies, our results clearly confirm that NMH is 
significantly better accommodated within MAO B as evidenced 
in a negative ∆Gbind value. This conclusion is strongly supported 
by a particularly impressive agreement between the calculated 
∆Gbind(NMH) = –5.6 kcal mol–1 and the related experimental 
value of ∆Gbind = –5.2 kcal mol–1, derived from the only available 
experimentally measured Km(NMH) value of 166 ± 8.1 μM.[11] 
Although the matching quantitative agreement for HIS is only 
moderate, the results in Table 1 are very useful in indicating that 
intrinsic gas-phase binding enthalpies are practically the same 
for both substrates, so are the entropic contributions, which is 
sensible knowing the structural similarity among both substrates. 
Difference in the MAO B selectivity towards NMH and HIS 
originates from different enzyme solvation enthalpy term, ∆Hsolv, 
which is much less-positive for NMH, thus leading to more 
exergonic and favourable binding. This suggests that MAO B is 
somewhat better preorganized to accommodate NMH, being 
fully in line with the observed stabilizing hydrophobic interactions 
reported for NMH here, in this way contributing to the MAO B 
selectivity. In ending this section, we note in passing that 
estimated errors of the MM–PBSA calculations shown in Table 1 
are an order of magnitude lower than the discussed ∆Gbind 
values, offering some validity to the presented conclusions. 
Although the focus of this work is on relative differences in 
the MAO B selectivity towards two very similar substrates, a 
somewhat significant mismatch between the calculated and 
experimentally derived ∆Gbind values for HIS deserves some 
comment. Given the complexity of computationally evaluating 
binding free energies of small molecules within large biological 
systems, and the known imperfections in the used state-of-the-
art MM–PBSA approach,[28] a quantitative disagreement of 6.1 
kcal mol–1 would, to some extent, even be acceptable for this 
kind of calculations. Still, this points to a conceptual difference, 
since the experimental value is negative (∆Gbind < 0), suggesting 
a favourable binding, while the computational value is positive 
(∆Gbind > 0), indicating an unlikely binding of HIS to the MAO B 
active site (Table 1). Even though the measured ∆Gbind for NMH 
is around 2 kcal mol–1 more exergonic, thus correctly implying a 
little competition between NMH and HIS for the MAO B binding 
when both substrates are present, the experimental ∆Gbind(HIS) 
= –3.3 kcal mol–1 would not help in explaining the experimental 
fact that HIS alone is not at all a physiological MAO B substrate, 
but has to be N-methylated before the enzymatic conversion.[18] 
While the value for NMH was precisely measured at Km = 166 ± 
8.1 μM,[11] Edmondson and co-workers experienced difficulties in  
Table 1. MM–PBSA calculated binding free energies (∆Gbind) and their components[a] for the monocationic histamine (HIS) and N-methylhistamine 
(NMH) within the MAO B active site (in kcal mol–1). 
System EVDW Eelec EPB Enonpolar ∆Hgas ∆Hsolv ∆Hbind T∆S ∆Gbind[b] ∆Gbind,EXP[c] Km[c,d] kcat / Km[c,e] 
HIS –15.0 –139.1 144.7 –3.2 –154.1 141.5 –12.6 –15.3 2.8 ± 0.8 –3.3 ~4000 0.875  
NMH –23.3 –131.4 136.6 –3.3 –154.7 133.3 –21.4 –15.8 –5.6 ± 0.5 –5.2 166 ± 8.1 210.8 
[a] EVDW = van der Waals contribution from MM; Eelec = electrostatic energy calculated by the MM force field; EPB = electrostatic contribution to the 
solvation free energy calculated by PB; Enonpolar = nonpolar contribution to the solvation free energy calculated by empirical model. [b] Standard errors 
(SE) are calculated as SE = SD / √(sample size), where SD = standard deviation and sample size was 100 structures in our case. [c] Experimental 
results from Edmondson and co-workers.[11] [d] in μM. [e] in min–1 μM–1 × 1000. 
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Figure 4. Structures of relevant stationary points for the MAO B catalyzed degradation of N-methylhistamine (NMH) within a cluster model of the enzyme. 
Geometries of the corresponding systems with histamine (HIS) are analogous. 
measuring the in vitro Km data for HIS and reported only an 
approximate value of Km ~ 4000 μM,[11] which leads us to 
conclude that it is likely associated with some uncertainty and 
perhaps somewhat overestimating the binding. In addition, 
experimental Km values[11] were not attained using the complex 
two substrate kinetics with both amine and oxygen,[29] which was 
shown by Ramsay and co-workers can give 1–2 kcal mol–1 
variations in the Km values for the oxidised and reduced forms of 
MAO B.[29] All of this sheds some concerns about a direct 
comparability among measured and computed ∆Gbind(HIS), and 
data reported here should primarily be regarded in terms of their 
interrelation, which indicates a trend that is strongly in line with 
experiments, and less from the viewpoint of the absolute 
agreement with experimental values. Taken all together, we feel 
that a more precise ∆Gbind,EXP(HIS) should be closer to zero, or 
even slightly positive, which would then be more consistent with 
the fact that HIS is not at all metabolized by MAO B in vivo.[18]  
 
Quantum Mechanical Analysis of the Catalytic Reaction. 
Following molecular dynamics simulations, we created a cluster 
model of the MAO B enzyme with both HIS and NMH substrates, 
including the FAD co-factor and Tyr60, Tyr188, Tyr326, Tyr398, 
Tyr435 and Gln206 residues, together with two active site water 
molecules, whose initial positions are analogous to those in the 
available MAO B crystal structure[25] and which we previously 
demonstrated are chemically involved in the catalysis.[9] M06–
2X/6–31G(d) optimization gave the initial stationary points 
corresponding to Michaelis reactant complexes (Figure 4). 
In reactants, both substrates are predominantly anchored 
through hydrogen bonds with Tyr326 and Tyr398, with the N(ring 
imino)–O(Tyr326) and N(chain amino)–O(Tyr398) distances at 
2.783 and 3.326 Å for HIS, and slightly shorter at 2.730 and 
3.015 Å for NMH, respectively. Even at this truncated model of 
the enzyme, these values indicate that NMH is somewhat better 
adjusted in the active site. Still, these pronounced interactions 
with the active site residues position the reacting α–CH fragment 
in NMH slightly further away from the flavin N5 atom, with the 
corresponding C(α)–N5 and H(α)–N5 distances at 3.452 and 
2.933 Å, respectively, being shorter in HIS at 3.300 and 2.671 Å. 
 Direct substrate α–hydride abstraction turned out to be 
feasible in both substrates (Figure 5), in agreement with our 
previous results for dopamine[9,10] and noradrenaline[20] 
degradations. In the transition state, the transferring hydrogen is 
placed between the leaving α–carbon and the accepting flavin 
N5 atom, with bond distances at 1.419 and 1.225 Å for HIS, 
respectively, being slightly more symmetrical in NMH at 1.398 
and 1.235 Å, in the same order. The free energy required for this 
process in NMH is 20.4 kcal mol–1 (νimag = 1414i cm–1), which is 
increased to 23.0 kcal mol–1 in HIS (νimag = 1260i cm–1), being in 
full agreement with the experimentally determined selectivity of 
MAO B towards these two substrates. The fact that this process 
is indeed associated with the transfer of a hydride anion (H–) is 
evident in the calculated atomic charges (Table 2). Initially, total 
charges on NMH and the FAD co-factor in the reactants are 0.03 
and –0.03 |e|, respectively, to be altered to 0.30 and –0.31 |e| in 
the transition state, respectively, thus indicating that during the 
reaction NMH loses around one third of an electron which is 
subsequently accommodated on FAD. In addition, the charge on 
 
 
Figure 5. Free energy profiles for the MAO B catalyzed histamine (in red) and 
N-methylhistamine (in blue) degradation within a cluster model of the enzyme. 
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the accepting N5 atom changes from –0.36 in reactants to –0.48 
|e| in the transition state. This agrees well with the electrophilic 
nature of the flavin N5 atom, which was revealed after we 
demonstrated that the irreversible MAO B inhibition by 
acetylenic inhibitors rasagiline, selegiline and clorgyline could 
proceed through the nucleophilic attack of the terminally 
deprotonated anionic inhibitor onto the flavin N5 atom,[30,31] the 
resulting complex matching the available X-ray 
structures.[15b,25,32] Interestingly, the charge on the substrate α–
carbon atom, from which the H– anion is abstracted, changes 
only moderately from 0.23 to 0.33 |e|, which is rationalized by 
the presence of the neighbouring amino group that stabilizes the 
formed carbocation through electron donation. This is seen in 
the reduced charge on the amino nitrogen and the shortened 
N(amino)–C(α) distance, changing from –0.95 |e| and 1.495 Å in 
the reactants to –0.80 |e| and 1.349 Å in the transition state, 
which is all consistent with the proposed H– transfer. 
It is particularly important to discuss the charge distribution 
in initial reactants in the context of the polar nucleophilic 
mechanism, which was proposed as another alternative for the 
amine oxidation involving proton (H+) abstraction from the α–
carbon as the rate-limiting step.[33] The crucial issue relating to 
this mechanism is what moiety on the enzyme would be a strong 
enough base to perform this task, since the reacting C–H group 
is poorly acidic with typical pKa values as high as 25.[34] 
Structural analysis of both MAO isoforms shows there are no 
basic active-site residues that could act as proton acceptors.[35] 
Edmondson and co-workers upheld their arguments by stating 
that in MAOs the flavin co-factor is bent by around 30° from 
planarity about the N5–N10 axis, which enhances the basicity of 
the N5 atom and depletes the electron density on the C4a atom, 
thus facilitating substrate N(amino)–C4a(flavin) complex 
formation making subsequent proton abstraction possible,[35] 
although no direct evidence for a stable amine–flavin adduct has 
ever been found experimentally. We performed a relaxed-
geometry scan of the mentioned N(amino)–C4a(flavin) bond, 
starting from 2.875 Å in the reactants with NMH and 
compressing it with 0.1 Å increments. The results showed no 
indications of the formation of a stable complex accompanied 
only by an increase in the total energy to values over 40 kcal 
mol–1 for the corresponding bond lengths shorter than 1.375 Å. 
In addition, NBO charges on the flavin C4a and N5 sites and the 
substrate N(amino) atom in the reactants are 0.13, −0.36, and 
−0.95 |e|, respectively, being practically unchanged from the 
values in isolated flavin and NMH (0.12, −0.35, and −0.94 |e|; 
Table 2), revealing there is no significant charge transfer in the 
Michaelis complex. On the other hand, based on QM/MM results 
on benzylamines, Kästner and co-workers showed that a formal 
hydride transfer could occur in a concerted asynchronous way 
involving the preceding transfer of two electrons from the amino 
group followed by the C(α)–H proton transfer,[36a] which they 
attributed in favour of the polar nucleophilic mechanism, though 
they also failed to provide any evidence for a stable amine–flavin 
adduct, which was proposed to facilitate deprotonation.[35] They 
claim that about 30−40% of the charge is transferred from the 
substrate to the co-factor already in the reactants,[36a] but later 
showed that this critically depends on the substrate–flavin 
orientation and polarization effects of the enzyme environment 
(MAO A vs. MAO B).[36b] In contrast, data in Table 2 clearly show 
that only 3% of the charge is perturbed upon substrate binding, 
which, taken all together, suggests that neutral amines do not 
exhibit the necessary nucleophilicity to readily add to the flavin 
C4a position. This all led us to rule out the polar nucleophilic 
mechanism as feasible, in agreement with our previous 
results,[9,10,37] and very recent experiments.[13] This is further 
supported by analyzing the flavin geometry in reactants, which is 
not bent, but practically planar with dihedral angles around N5–
N10 axis of only 3.0 and 3.8° for NMH, and 0.8 and 1.0° for HIS. 
Following the initial hydride transfer, the system relaxes to 
the corresponding intermediates, which are characterized by the 
formed semi-reduced anionic flavin, FADH–, and the cationic 
substrate (Figures 4 and 5). This is indicated in the charge 
distribution, which shows that the full formation of the new N5–
H– bond increases the total charge on flavin to –0.89 |e|, while, 
accordingly, the charge on NMH becomes 0.84 |e|. The reaction 
with NMH is more favourable (∆Gr = –1.1 kcal mol–1), as the 
hydride abstraction in HIS is more endergonic (∆Gr = 5.9 kcal 
mol–1). It is important to emphasize that a significant difference 
Table 2. Charge distribution during the rate-limiting hydride abstraction step in the MAO B catalysis as obtained through the NBO analysis at the 
(CPCM)/M06–2X/6–31G(d) level. 
System Atom/Molecule Isolated Reactants TS Products 
 
N(amino) –0.94 –0.95 –0.80 –0.69 
α–H 0.23 0.24 0.33 0.43 
α–C –0.26 –0.27 –0.07 0.27 
β–C –0.51 –0.51 –0.52 –0.57 
N-methylhistamine 0.00 0.03 0.30 0.84 
 
N5 –0.35 –0.36 –0.48 –0.67 
C4a 0.12 0.13 –0.06 –0.11 
N1 –0.67 –0.67 –0.71 –0.73 
FAD co-factor 0.00 –0.03 –0.31 –0.89 
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compared with dopamine degradation is the fact that, in the 
intermediate, there is no adduct formation between flavin and 
either HIS or NMH as it was demonstrated to occur with 
dopamine (Scheme 3), where the N5(flavin)–C(α) adduct was 
rather stable (∆Gform = –27.7 kcal mol–1) and formed 
spontaneously following the H– transfer.[9] There, the adduct 
decomposed concertedly with the substrate free amino group 
deprotonation during the next step in the MAO catalysis, 
facilitated by the availability of the acidic amino N–H bond. This 
is why the adduct formation rationalizes why many alkyl- and 
arylamines change from being MAO substrates to irreversible 
MAO inhibitors upon N,N-dimethylation,[38] making the adduct 
formation with dopamine fully justified.[9] With HIS and NMH, we 
observed no spontaneous adduct formation, which is not 
strikingly surprising since these two systems are chemically 
different from dopamine. Instead, cationic NMH and HIS are well 
separated from flavin in the matching intermediates (Figure 4) 
with the C(α)–N5(flavin) distances being 2.872 and 2.575 Å, 
respectively. Still, our calculations show that the adduct 
formation is possible, however it is associated with a free energy 
barrier (5.2 kcal mol–1 for NMH and 4.9 kcal mol–1 for HIS), while 
the corresponding adducts are less stable than the initial 
intermediates (2.5 kcal mol–1 for NMH and 3.1 kcal mol–1 for HIS). 
All of this led us to conclude that adduct found for dopamine is 
very unlikely to form with NMH and HIS, and that the 
subsequent substrate N–H deprotonation could occur without 
prior adduct formation. 
 
Scheme 3. Schematic representation of the covalent adduct that is 
spontaneously formed between dopamine and the flavin co-factor within the 
MAO B active site following the hydride transfer as outlined in ref. 9.   
The next step in the amine degradation involves substrate 
amino group deprotonation by the flavin N1 atom to which it is 
connected with two active site waters through a network of 
hydrogen bonds (Figure 4). For example, in NMH the 
corresponding bond distances are N(NMH)–O(water1) = 2.690 Å, 
O(water1)–O(water2) = 2.733 Å, and O(water2)–N1 = 2.736 Å. 
This allows the amino N–H deprotonation assisted by the 
mentioned water molecules via the de Grotthuss mechanism.[39] 
This reaction is prompted by a negative charge build-up on the 
N1 atom following the hydride transfer (Table 2) and the fact that 
this site represents the most basic position within the co-factor 
moiety as demonstrated previously.[9] In NMH, this process is 
accompanied with the activation free energy of 4.8 kcal mol–1 
(νimag = 792i cm–1), which is slightly reduced in HIS to 2.8 kcal 
mol–1 (νimag = 834i cm–1). This shows that the barrier for the 
substrate N–H deprotonation is much lower than that for the 
hydride abstraction in both cases, suggesting that the latter 
process represents the rate-limiting step of the overall 
transformation, being in full agreement with our earlier 
results[9,10,37] and recent experiments.[13] The low barrier of the 
second step is easily rationalized if one considers the 
corresponding pKa values of the interacting sites. Namely, 
protonated imines are significantly more N–H acidic than neutral 
imines or amines, and are typically associated with pKa ≈ 5–7,[34] 
which is well matched with the basicity of the N1 position in 
semi-reduced flavin FADH– that was experimentally estimated to 
be around pKa ≈ 7,[40] thus the low barrier for the proton transfer. 
Upon deprotonation, the system gets stabilized by 4.8 kcal mol–1 
in HIS and much significantly by 7.9 kcal mol–1 in NMH, which, in 
the latter, makes the whole reaction energetically feasible 
(Figure 5). In other words, the overall transformation in NMH is 
exergonic, ∆Gr = –4.2 kcal mol–1, while in HIS it is endergonic, 
∆Gr = 3.9 kcal mol–1, thus making a significant contribution in 
rationalizing the selectivity of MAO B towards these substrates. 
In addition, the overall profile for NMH is favourable as it 
proceeds downhill in energy through stationary points at relative 
energies of 0.0, –1.1 and –4.2 kcal mol–1, with the rate limiting 
hydride abstraction. The presented two-step process gives the 
neutral trans-imine and the fully reduced flavin as final products 
(Figure 4). The fact that flavin is fully reduced to FADH2 enables 
an essential prerequisite for MAO regeneration by molecular 
oxygen, O2, to revert flavin to its oxidized form, FAD, by 
producing hydrogen peroxide, H2O2, the reaction for which two 
hydrogen atoms are required. This gives a comparative 
advantage to our mechanistic picture in comparison with other 
proposals for MAO catalysis, which all advise flavin reduction to 
FADH– only.[33,37,38]  
In finishing this section, it is very important to put the 
obtained activation free energies in the right perspective. At first 
sight, the calculated ∆G‡(NMH) = 20.4 kcal mol–1 and ∆G‡(HIS) 
= 23.0 kcal mol–1 appear off from experimental ∆G‡EXP(NMH) = 
17.8 kcal mol–1 and ∆G‡(HIS) = 19.2 kcal mol–1, which are 
derived from the measured kcat(NMH) = 35 min–1 and kcat(HIS) = 
3.5 min–1 values.[11] Still, it has to be emphasized that both of the 
calculated values are found well within the estimated error of the 
QM–cluster approach of 5 kcal mol–1, assessed by Siegbahn 
and co-workers on the basis of extensive calculations for a large 
number of enzymes.[41] This approach uses a relatively small but 
well-chosen part of the enzyme, and it turned out very useful in 
revealing the feasibility of the direct hydride mechanism.[9,10,37] It 
is obvious that this computational methodology could be 
improved by either including a larger portion of the enzyme 
within this framework, or by considering the full dimensionality of 
the MAO B enzyme employing any of the established QM/MM 
techniques. To further refine the activation free energy, one 
could also proceed with the quantization of the hydrogen nuclear 
motion through path integral approaches[42a] or implicit 
schemes,[42b] giving rise to tunnelling,[43] which would additionally 
lower the barrier. The experimental value of the H/D kinetic 
isotope effect for MAO B is between 6–13,[33] suggesting 
significant tunnelling,[44] and giving additional evidence in 
support of the polar hydride transfer mechanism.[42a] 
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Nevertheless, the focus of this work was in rationalizing relative 
differences in the MAO B selectivity towards HIS and NMH, and, 
in that context, a very small difference in the experimental in 
vitro activation free energies of ∆∆G‡EXP = 1.4 kcal mol–1 is very 
well reproduced by our calculations (∆∆G‡CALC = 2.6 kcal mol–1). 
As a final point, we would like to reiterate that, following our 
earlier QM cluster results for dopamine,[9] the EVB QM/MM 
simulations brought the calculated barrier down from 24.4 kcal 
mol–1 to 16.1 kcal mol–1,[10] being in almost perfect agreement 
with experiments (16.5 kcal mol–1),[11] thus supporting the 
hydride transfer mechanism. Therefore, we are confident that all 
conclusions regarding the MAO B selectivity consistently drawn 
from various computational techniques presented here are valid 
and convincing. Still, it remains a challenge to study the MAO 
catalysis with the NMH and HIS substrates through a 
combination of the QM/MM and path integral approaches, and 
although these are beyond the scope of the current manuscript, 
both aspects should bring calculated free energy barriers even 
closer to experiments and will be addressed in our future work. 
Conclusions 
In this work we used molecular dynamics simulations, MM–
PBSA binding free energy evaluations, and quantum mechanical 
cluster calculations to investigate the specificity of the MAO B 
enzyme towards important neurotransmitter and signalling 
molecule histamine (HIS) and its N-methylhistamine derivative 
(NMH). Our results help in rationalizing the fact that HIS is not at 
all a physiological MAO B substrate, but has to be N-methylated 
to NMH before the enzymatic conversion, by showing that a 
dominant contribution for the MAO B selectivity is exerted in a 
2.6 kcal mol–1 lower activation free energy for NMH for the rate-
limiting hydride abstraction, in a very good agreement with the 
experimental value of ∆∆G‡EXP = 1.4 kcal mol–1.[11] For otherwise 
a very promiscuous enzyme, this unexpected and intriguing in 
vivo MAO B selectivity towards two substrates, identical in their 
reactive ethylamino fragments and differing only in a methyl 
group far from the reactive centre, is further promoted by several 
contributions. Firstly, NMH is less flexible within the active site 
due to its higher tendency to form rigid conformations with the 
intramolecular N(amino)–N(imino) hydrogen bonding, allowing 
NMH to spend more time in reactive orientations towards the 
flavin co-factor. On the other hand, HIS is less likely to form 
intramolecular hydrogen bonds and is more flexible, which often 
yields unreactive conformations that are additionally encouraged 
by the presence of the acidic N–H fragment on its imidazole ring 
permitting HIS to make unproductive hydrogen bonds with active 
site residues and the flavin co-factor itself. Secondly, the N–Me 
group on the imidazole ring in NMH favours its better binding 
through hydrophobic interactions with the side chains of Leu171, 
Leu328 and the "gating" Ile199 residue that all keep NMH 
anchored in the active site and properly oriented for the reaction. 
This is evident in the calculated MM–PBSA binding free 
energies, which predict more favourable binding for NMH (∆Gbind 
= –5.6 kcal mol–1) than for HIS (∆Gbind = 2.8 kcal mol–1), the 
former being in excellent agreement with the only available 
experimental value of –5.2 kcal mol–1. Thirdly, the enzymatic 
transformation for both substrates follows our two-step hydride 
transfer mechanism, but the process is thermodynamically much 
more feasible for NMH, where the overall reaction free energy is 
exorgenic (∆Gr = –4.2 kcal mol–1), while for HIS it is endergonic 
(∆Gr = 3.9 kcal mol–1), thus unfavourable. 
Our results provide the molecular interpretation and 
identification of structural determinants for the substrate 
specificity of the MAO B enzyme. The calculated free energy 
profiles are consistent with the hydride mechanism, where in the 
rate-limiting first step the flavin N5 atom abstracts the hydride 
anion from the substrate α–carbon, which is followed by the 
vicinal substrate N(amino)–H deprotonation by the flavin N1 
atom assisted by two water molecules through de Grotthuss 
mechanism. In recent years, there have been several additional 
computational studies showing its prevailing energetic feasibility 
in MAO[12] or some other flavoenzymes,[45] together with a recent 
13C kinetic isotope effect measurements in a related polyamine 
oxidase flavoenzyme[13] that are strongly in line with the hydride 
transfer from the neutral amine. This study confirms the 
hydrophobic nature of the MAO B active site and underlines the 
important role of the Leu171, Leu328 and Ile199 residues in 
properly orienting substrates for the reaction. This insight might 
turn useful in rational modification of the MAO B reactivity in 
order to offer opportunities to exploit this enzyme in 
biotechnology and protein engineering, and in providing 
guidelines for designing more potent and selective MAO 
inhibitors that are all clinically employed in treating a variety of 
neuropsychiatric and neurodegenerative conditions. 
Computational Section 
Molecular dynamics simulations. The starting point for our calculations 
was the high-resolution (1.6 Å) X-ray structure of MAO B complexed with 
2-(2-benzofuranyl)-2-imidazoline[25] obtained from the Protein Data Bank 
(accession code 2XFN). Original crystal waters were removed from the 
structure so that water molecules from the bulk solvent could diffuse into 
the active site during equilibration and production MD runs. The protein 
exists as a homodimer with covalently bound FAD co-factor to the 
conserved Cys397 residue in each subunit. Protonation states of 
ionisable residues were set according to PROPKA3.1 server 
predictions[46] and by inspecting hydrogen bonding networks in their 
closest vicinity, while the missing hydrogen atoms were added using the 
tleap module in AmberTools15.[47] For the FAD co-factor and both HIS 
and NMH substrates, geometry optimization and RESP charge 
calculations were performed with the Gaussian 09 program[48] at the 
HF/6–31G(d) level to be consistent with the employed GAFF force field, 
while the enzyme was modelled using the AMBER ff14SB force field. 
Since several experimental studies[49] and our previous computational 
results[24] have agreed in showing that MAO substrates are likely bound 
to the active site as monocations protonated at the chain amino group, 
which is usually the most abundant form of monoamines at physiological 
pH, we prepared two complexes involving monocationic HIS and NMH in 
their most stable Nτ–H (N3–H) tautomeric forms[21a,50] each placed in both 
MAO B subunits. Thus formed protein complexes were solvated in a 
truncated octahedral box of TIP3P water molecules spanning a 10 Å 
thick buffer and submitted to geometry optimization in AMBER14 
program.[47] Optimized systems were gradually heated from 0 to 300 K 
and equilibrated during 30 ps using NVT conditions followed by 
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productive and unconstrained MD simulations of 300 ns employing a time 
step of 2 fs at constant pressure (1 atm) and temperature (300 K), the 
latter held constant using Langevin thermostat with a collision frequency 
of 1 ps–1. Bonds involving hydrogen atoms were constrained using the 
SHAKE algorithm,[51] while the long-range electrostatic interactions were 
calculated employing the Particle Mesh Ewald method.[52] The 
nonbonded interactions were truncated at 10.0 Å. Following MD 
simulations, the obtained structures were clustered according to the 
distance between the reactive αC(substrate)–N5(flavin) atoms on every 
10th structure from the last 100 ns of simulations corresponding to the A 
subunit of the dimeric MAO B. Analogously, structures from the A subunit 
were also employed for all of the subsequent analyses here.  
Free energy calculations. The binding free energy, ∆Gbind, of HIS and 
NMH within MAO B were calculated using the MM–PBSA protocol,[53] 
which is the widely used method for binding free energy calculations from 
the snapshots of MD trajectory[54] with an estimated standard error of 1–3 
kcal mol–1.[55] Within this approach, ∆Gbind is calculated as: 
∆Gbind = < Gcomplex > – < Genzyme> – < Gsubstrate >   (1) 
where the symbol < > represents the average value over 100 snapshots 
collected from the 5 ns part of the corresponding MD trajectory where 
both substrates are equally oriented in reactive conformation in the active 
site. The free energy of a system can be approximated by three terms: 
Gcomplex/enzyme/substrate = EMM + Gsolv – T•∆SMM    (2) 
where EMM, the gas-phase molecular mechanical energy, is obtained as 
a sum of Einternal, EVDW, and Eelec contributions. Gsolv, the solvation free 
energy, is a sum of polar (Gpolar) and nonpolar (Gnonpolar) components, 
where the former was calculated by solving the finite-difference 
Generalized Born equation, while the latter was determined on the basis 
of the solvent-accessible surface area (SASA) as: 
Gnonpolar = γ•SASA + β       (3) 
with recommended empirical parameters γ = 0.0054 kcal mol–1 Å–2 and β 
= 0.92 kcal mol–1.[56] The solute conformational entropy (SMM) was 
estimated by the normal-mode analysis based on 10 frames. The interior 
and exterior dielectric constants were set to 1 and 80, respectively.[57]  
Quantum mechanical analysis. Following MD simulations, we selected 
a snapshot structure for each substrate from the part of the 
corresponding trajectory where the system assumed lowest energies 
while, at the same time, HIS and NMH were found in reactive 
conformations with their ethylamino chains pointing towards the FAD co-
factor. This allowed us to build a cluster model of the MAO B enzyme by 
extracting initial positions of the substrate, FAD co-factor and Tyr60, 
Tyr188, Tyr326, Tyr398, Tyr435 and Gln206 residues, together with two 
active site water molecules whose positions were analogous to those of 
crystal structure waters HOH2329 and HOH2372, and which are, 
according to our previous calculations[9,37] in the right place to be 
chemically involved during catalysis. FAD co-factor was truncated at the 
ethyl group on the N10 atom, while all selected amino acids were 
truncated at their α-carbon atoms, which were kept in the form of the 
methyl group. All of the latter atom centres were used as anchor points 
and their positions were kept frozen during calculations. As mentioned, 
while MAO substrates are likely bound to the active site in their 
protonated forms, both experiments[49,58] and calculations[9,10,20,36] agree 
in indicating that the substrate neutral form is mandatory for the hydride 
abstraction. In the absence of basic residues in the active site,[35] 
substrate deprotonation before the enzymatic reaction could be achieved 
by several water molecules present in the enzyme. Hence, we striped 
one proton from each substrate and left them as neutral systems for the 
QM analysis. In order to minimize errors associated with the initial 
selection of starting geometries from MD trajectories, we tried several 
conformations of each substrate within the so-formed cluster and went on 
with the mechanistic calculations using the most stable complexes.  
As a good compromise between accuracy and the computational 
feasibility, all geometries were optimized by the very efficient M06–2X/6–
31G(d) method with thermal Gibbs free energy corrections extracted from 
the corresponding frequency calculations without the scaling factors. The 
final single-point energies were attained with a highly flexible 6–
311++G(2df,2pd) basis set employing M06–2X, BMK, PBE0 and B3LYP 
DFT functionals. PBE0 offered results in closest agreement with 
experiments, and, together with the BMK and B3LYP results, provided 
barriers which are consistently lower than those with the M06–2X 
functional (Table S1), which is why PBE0 results are discussed 
throughout the text. In the applied cluster methodology, a truncated but 
carefully selected part of the enzyme is treated with the quantum 
mechanical methodology in accordance with our earlier work.[9,10,37] To 
account for polarization effects caused by the rest of the enzyme, we 
included, during both geometry optimization and single-point energy 
calculation, a conductor-like polarisable continuum model (CPCM)[59] with 
a common dielectric constant of ε = 4 and other parameters 
corresponding to pure water, as employed in many articles by Siegbahn, 
Himo and their co-workers in elucidating the catalytic mechanism of a 
large variety of enzymes.[60] This yields the (CPCM)/PBE0/6–
311++G(2df,2pd)//(CPCM)/M06–2X/6–31G(d) model used here. Some 
validity to the choice of the cluster model to study enzyme catalysis is 
also provided through very recent papers by Warshel[61a] and 
Martínez[61b] and their co-workers, who demonstrated that in QM/MM 
approaches, which consider the full enzyme structure, the calculated 
activation barriers are not highly sensitive to the size of the QM region, 
beyond the immediate region that describes the reacting atoms. Hence, a 
reasonably large QM cluster employed here in conjunction with the 
implicit polarisable continuum representation of the rest of the enzyme 
should give reliable results. All of the transition state structures were 
verified to have the appropriate imaginary frequencies, from which the 
corresponding reactants and products were determined by the intrinsic 
reaction coordinate (IRC) procedure. Atomic charges were obtained by 
natural bond orbital (NBO)[62] analyses as the single-point calculations at 
the (CPCM)/M06–2X/6–31G(d) level of theory. All calculations were 
performed by using the Gaussian 09 software.[47]  
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